Yi J, Gong WD, Wang L, Ling R, Chen JH, Yun J. VP22 fusion protein-based dominant negative mutant can inhibit hepatitis B virus replication. World J Gastroenterol 2005; 11(41): 6429-6432 [PMID: 16425411 DOI: 10.3748/wjg.v11.i41.6429]
Corresponding Author of This Article
Wei-Dong Gong, Oncology Center, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong Province, China. gongwd70@fmmu.edu.cn.
Article-Type of This Article
Viral Hepatitis
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/